Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07366333 · ClinicalTrials.gov registry record · NA
ThriveCircles for Well-Being at CU SOM
A NA study, sponsored by University of Colorado, Denver.
- Not yet
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT07366333: Clinical Trial NA study, sponsored by University of Colorado, Denver.
NCT07366333 is a NA study that has not yet begun recruiting, run by University of Colorado, Denver. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07366333, a NA study, has not yet begun recruiting, sponsored by University of Colorado, Denver.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This study is testing a program called ThriveCircle, which brings small groups of faculty members together to talk about their work experiences, support one another, and build a stronger sense of community. These groups meet over shared meals and use guided conversations to help reduce burnout and improve well-being among clinicians and scientists.
Primary Outcome
Maslach Burnout Inventory - Human Services Survey for Medical Personnel (MBI-HSS MP) is a 22-item survey that covers 3 areas: Emotional Exhaustion (EE, range 0-54, higher score greater EE), Depersonalization (DP, range 0 - 30, higher score greater DP), and low sense of Personal Accomplishment (PA, range 0 -48, higher score greater PA). Each subscale includes multiple questions with frequency rating choices of Never, A few times a year or less, Once a month or less, A few times a month, Once a we
Interventions
- BEHAVIORAL ThriveCircle Peer-Led Well-Being Groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-05-18 |
| Est. Completion | 2027-10-30 |
| Phase | NA |
What is known before NCT07366333 opens enrollment
NCT07366333 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which ThriveCircle Peer-Led Well-Being Groups is the first listed.
NCT07366333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07366333 about?
NCT07366333 is a clinical study titled "ThriveCircles for Well-Being at CU SOM". This study is testing a program called ThriveCircle, which brings small groups of faculty members together to talk about their work experiences, support one another, and build a stronger sense of community. These groups meet over shared meals and use guided conversations to help reduce burnout and i...
What is the current status of trial NCT07366333?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2026-05-18. Estimated completion is 2027-10-30.
What interventions are being tested in trial NCT07366333?
The interventions under investigation include: ThriveCircle Peer-Led Well-Being Groups (BEHAVIORAL).
Who is sponsoring clinical trial NCT07366333?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07366333's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI